Amphastar Pharmaceuticals AMPH Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's net income?
- Amphastar Pharmaceuticals (AMPH) reported net income of $6.42M in Q1 2026.
- How has Amphastar Pharmaceuticals's net income changed year-over-year?
- Amphastar Pharmaceuticals's net income decreased by 74.6% year-over-year, from $25.29M to $6.42M.
- What is the long-term trend for Amphastar Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's net income has grown at a 12.1% compound annual growth rate (CAGR), from $62.12M to $98.09M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.